Logo image of GBT.PA

GUERBET (GBT.PA) Stock Fundamental Analysis

EPA:GBT - Euronext Paris - Matif - FR0000032526 - Common Stock - Currency: EUR

27  +0.7 (+2.66%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to GBT. GBT was compared to 60 industry peers in the Health Care Equipment & Supplies industry. GBT has only an average score on both its financial health and profitability. GBT is valued quite cheap, while showing a decent growth score. This is a good combination!


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

GBT had positive earnings in the past year.
GBT had a positive operating cash flow in the past year.
GBT had positive earnings in 4 of the past 5 years.
GBT had a positive operating cash flow in each of the past 5 years.
GBT.PA Yearly Net Income VS EBIT VS OCF VS FCFGBT.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50M 100M

1.2 Ratios

GBT's Return On Assets of 3.14% is in line compared to the rest of the industry. GBT outperforms 54.55% of its industry peers.
GBT's Return On Equity of 8.43% is fine compared to the rest of the industry. GBT outperforms 67.27% of its industry peers.
GBT's Return On Invested Capital of 5.26% is fine compared to the rest of the industry. GBT outperforms 63.64% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for GBT is below the industry average of 7.96%.
The 3 year average ROIC (3.89%) for GBT is below the current ROIC(5.26%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 3.14%
ROE 8.43%
ROIC 5.26%
ROA(3y)0.4%
ROA(5y)1.37%
ROE(3y)1.18%
ROE(5y)3.62%
ROIC(3y)3.89%
ROIC(5y)4.11%
GBT.PA Yearly ROA, ROE, ROICGBT.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 5 -5 10 -10

1.3 Margins

GBT has a Profit Margin (3.97%) which is comparable to the rest of the industry.
GBT's Profit Margin has declined in the last couple of years.
GBT has a Operating Margin of 7.10%. This is comparable to the rest of the industry: GBT outperforms 56.36% of its industry peers.
In the last couple of years the Operating Margin of GBT has declined.
With an excellent Gross Margin value of 78.58%, GBT belongs to the best of the industry, outperforming 81.82% of the companies in the same industry.
In the last couple of years the Gross Margin of GBT has remained more or less at the same level.
Industry RankSector Rank
OM 7.1%
PM (TTM) 3.97%
GM 78.58%
OM growth 3Y-6.04%
OM growth 5Y-9.85%
PM growth 3Y5.86%
PM growth 5Y-12.52%
GM growth 3Y0.51%
GM growth 5Y0.53%
GBT.PA Yearly Profit, Operating, Gross MarginsGBT.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20 40 60

4

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GBT is destroying value.
Compared to 1 year ago, GBT has about the same amount of shares outstanding.
The number of shares outstanding for GBT has been increased compared to 5 years ago.
The debt/assets ratio for GBT is higher compared to a year ago.
GBT.PA Yearly Shares OutstandingGBT.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2M 4M 6M 8M 10M
GBT.PA Yearly Total Debt VS Total AssetsGBT.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M 800M 1B

2.2 Solvency

An Altman-Z score of 2.28 indicates that GBT is not a great score, but indicates only limited risk for bankruptcy at the moment.
GBT has a Altman-Z score (2.28) which is in line with its industry peers.
GBT has a debt to FCF ratio of 23.24. This is a negative value and a sign of low solvency as GBT would need 23.24 years to pay back of all of its debts.
The Debt to FCF ratio of GBT (23.24) is comparable to the rest of the industry.
GBT has a Debt/Equity ratio of 0.97. This is a neutral value indicating GBT is somewhat dependend on debt financing.
The Debt to Equity ratio of GBT (0.97) is worse than 78.18% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 23.24
Altman-Z 2.28
ROIC/WACC0.98
WACC5.37%
GBT.PA Yearly LT Debt VS Equity VS FCFGBT.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

2.3 Liquidity

GBT has a Current Ratio of 2.52. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
GBT has a Current ratio of 2.52. This is in the better half of the industry: GBT outperforms 70.91% of its industry peers.
A Quick Ratio of 1.16 indicates that GBT should not have too much problems paying its short term obligations.
With a Quick ratio value of 1.16, GBT perfoms like the industry average, outperforming 60.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 1.16
GBT.PA Yearly Current Assets VS Current LiabilitesGBT.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 200M 400M 600M

5

3. Growth

3.1 Past

GBT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 177.50%, which is quite impressive.
Measured over the past years, GBT shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -12.65% on average per year.
GBT shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 8.60%.
The Revenue has been decreasing by -0.10% on average over the past years.
EPS 1Y (TTM)177.5%
EPS 3Y9.29%
EPS 5Y-12.65%
EPS Q2Q%443.75%
Revenue 1Y (TTM)8.6%
Revenue growth 3Y3.32%
Revenue growth 5Y-0.1%
Sales Q2Q%10.71%

3.2 Future

GBT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 50.65% yearly.
The Revenue is expected to grow by 6.51% on average over the next years.
EPS Next Y119.14%
EPS Next 2Y67.46%
EPS Next 3Y50.65%
EPS Next 5YN/A
Revenue Next Year6.69%
Revenue Next 2Y6.68%
Revenue Next 3Y6.51%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
GBT.PA Yearly Revenue VS EstimatesGBT.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 200M 400M 600M 800M
GBT.PA Yearly EPS VS EstimatesGBT.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3 4

9

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 10.23, the valuation of GBT can be described as very reasonable.
Based on the Price/Earnings ratio, GBT is valued cheaper than 94.55% of the companies in the same industry.
When comparing the Price/Earnings ratio of GBT to the average of the S&P500 Index (29.35), we can say GBT is valued rather cheaply.
GBT is valuated reasonably with a Price/Forward Earnings ratio of 8.20.
Based on the Price/Forward Earnings ratio, GBT is valued cheaper than 92.73% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of GBT to the average of the S&P500 Index (22.10), we can say GBT is valued rather cheaply.
Industry RankSector Rank
PE 10.23
Fwd PE 8.2
GBT.PA Price Earnings VS Forward Price EarningsGBT.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 94.55% of the companies listed in the same industry.
GBT's Price/Free Cash Flow ratio is rather cheap when compared to the industry. GBT is cheaper than 90.91% of the companies in the same industry.
Industry RankSector Rank
P/FCF 19.88
EV/EBITDA 5.02
GBT.PA Per share dataGBT.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
A more expensive valuation may be justified as GBT's earnings are expected to grow with 50.65% in the coming years.
PEG (NY)0.09
PEG (5Y)N/A
EPS Next 2Y67.46%
EPS Next 3Y50.65%

4

5. Dividend

5.1 Amount

GBT has a Yearly Dividend Yield of 1.90%.
GBT's Dividend Yield is rather good when compared to the industry average which is at 2.26. GBT pays more dividend than 87.27% of the companies in the same industry.
GBT's Dividend Yield is comparable with the S&P500 average which is at 2.33.
Industry RankSector Rank
Dividend Yield 1.9%

5.2 History

The dividend of GBT decreases each year by -10.14%.
Dividend Growth(5Y)-10.14%
Div Incr Years0
Div Non Decr Years1
GBT.PA Yearly Dividends per shareGBT.PA Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 0.2 0.4 0.6 0.8

5.3 Sustainability

19.26% of the earnings are spent on dividend by GBT. This is a low number and sustainable payout ratio.
DP19.26%
EPS Next 2Y67.46%
EPS Next 3Y50.65%
GBT.PA Yearly Income VS Free CF VS DividendGBT.PA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 20M -20M 40M -40M 60M
GBT.PA Dividend Payout.GBT.PA Dividend Payout, showing the Payout Ratio.GBT.PA Dividend Payout.PayoutRetained Earnings

GUERBET

EPA:GBT (3/7/2025, 7:00:00 PM)

27

+0.7 (+2.66%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-24 2024-10-24
Earnings (Next)03-26 2025-03-26/amc
Inst Owners18.97%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap341.28M
Analysts85
Price Target42.59 (57.74%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 1.9%
Yearly Dividend0.5
Dividend Growth(5Y)-10.14%
DP19.26%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-1.76%
PT rev (3m)-1.76%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)-1.16%
EPS NY rev (3m)-0.78%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-1.41%
Revenue NY rev (3m)-1.41%
Valuation
Industry RankSector Rank
PE 10.23
Fwd PE 8.2
P/S 0.41
P/FCF 19.88
P/OCF 4.85
P/B 0.88
P/tB 1.16
EV/EBITDA 5.02
EPS(TTM)2.64
EY9.78%
EPS(NY)3.29
Fwd EY12.19%
FCF(TTM)1.36
FCFY5.03%
OCF(TTM)5.57
OCFY20.64%
SpS65.37
BVpS30.74
TBVpS23.21
PEG (NY)0.09
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.14%
ROE 8.43%
ROCE 7.31%
ROIC 5.26%
ROICexc 5.97%
ROICexgc 6.9%
OM 7.1%
PM (TTM) 3.97%
GM 78.58%
FCFM 2.08%
ROA(3y)0.4%
ROA(5y)1.37%
ROE(3y)1.18%
ROE(5y)3.62%
ROIC(3y)3.89%
ROIC(5y)4.11%
ROICexc(3y)4.63%
ROICexc(5y)4.93%
ROICexgc(3y)5.9%
ROICexgc(5y)6.6%
ROCE(3y)5.4%
ROCE(5y)5.72%
ROICexcg growth 3Y-13.75%
ROICexcg growth 5Y-21.27%
ROICexc growth 3Y-7.17%
ROICexc growth 5Y-16.1%
OM growth 3Y-6.04%
OM growth 5Y-9.85%
PM growth 3Y5.86%
PM growth 5Y-12.52%
GM growth 3Y0.51%
GM growth 5Y0.53%
F-Score6
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0.97
Debt/FCF 23.24
Debt/EBITDA 3.22
Cap/Depr 91.01%
Cap/Sales 6.45%
Interest Coverage 3.62
Cash Conversion 60.12%
Profit Quality 52.4%
Current Ratio 2.52
Quick Ratio 1.16
Altman-Z 2.28
F-Score6
WACC5.37%
ROIC/WACC0.98
Cap/Depr(3y)74.11%
Cap/Depr(5y)85.33%
Cap/Sales(3y)6.87%
Cap/Sales(5y)7.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)177.5%
EPS 3Y9.29%
EPS 5Y-12.65%
EPS Q2Q%443.75%
EPS Next Y119.14%
EPS Next 2Y67.46%
EPS Next 3Y50.65%
EPS Next 5YN/A
Revenue 1Y (TTM)8.6%
Revenue growth 3Y3.32%
Revenue growth 5Y-0.1%
Sales Q2Q%10.71%
Revenue Next Year6.69%
Revenue Next 2Y6.68%
Revenue Next 3Y6.51%
Revenue Next 5YN/A
EBIT growth 1Y336.72%
EBIT growth 3Y-2.91%
EBIT growth 5Y-9.94%
EBIT Next Year396.95%
EBIT Next 3Y82.59%
EBIT Next 5YN/A
FCF growth 1Y3.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y4.99%
OCF growth 3Y-38.93%
OCF growth 5Y-18.63%